Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers
Estrogen receptor alpha (ERα) marks heterogeneous breast cancers which display a repertoire of somatic genomic mutations and an immune environment that differs from other breast cancer subtypes. These cancers also exhibit distinct biological behaviors; despite an overall better prognosis than HER2+...
Main Authors: | Linda A. Schuler, Fern E. Murdoch |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3725 |
Similar Items
-
Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
by: Kathleen A. O’Leary, et al.
Published: (2023-06-01) -
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
by: Rainer Girgert, et al.
Published: (2019-01-01) -
The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
by: David Rodriguez, et al.
Published: (2019-07-01) -
Editorial: The tumor and microenvironment crosstalk in breast cancer: from biology to therapeutic opportunity
by: Marta Truffi, et al.
Published: (2024-01-01) -
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy
by: Andrea Nicolini, et al.
Published: (2024-03-01)